Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: Marc Kahn who wrote (183)	5/16/1998 2:52:00 PM
From: GREG FINLEY	Respond to of 534

Thanks Marc, I really appreciate you taking the time to relay that me (and the rest of the people on this BB). I had a response to my question of #181 on the Yahoo BB, and I was satisfied that the affect of the spray on BJCT's market will be nil. In essence, it appears that the main market for the spray will be children under 5. I will contact BJCT to get on the mailing list that I thought I was on already! (I own a lot of this company, having been a shareholder and a believer in their management and product since July '96). I think this company is a pure winner, with a great opportunity to be a major player in several medical fields. GREG